JP2021535209A5 - - Google Patents
Info
- Publication number
- JP2021535209A5 JP2021535209A5 JP2021534405A JP2021534405A JP2021535209A5 JP 2021535209 A5 JP2021535209 A5 JP 2021535209A5 JP 2021534405 A JP2021534405 A JP 2021534405A JP 2021534405 A JP2021534405 A JP 2021534405A JP 2021535209 A5 JP2021535209 A5 JP 2021535209A5
- Authority
- JP
- Japan
- Prior art keywords
- formula
- peptide compound
- seq
- use according
- cancer cells
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862722726P | 2018-08-24 | 2018-08-24 | |
| US62/722,726 | 2018-08-24 | ||
| US201962804063P | 2019-02-11 | 2019-02-11 | |
| US62/804,063 | 2019-02-11 | ||
| PCT/CA2019/051170 WO2020037434A1 (en) | 2018-08-24 | 2019-08-26 | Methods and compounds for targeting sortilin receptors and inhibiting vasculogenic mimicry |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2021535209A JP2021535209A (ja) | 2021-12-16 |
| JP2021535209A5 true JP2021535209A5 (cg-RX-API-DMAC7.html) | 2022-08-29 |
| JP7592320B2 JP7592320B2 (ja) | 2024-12-02 |
Family
ID=69591094
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021534405A Active JP7592320B2 (ja) | 2018-08-24 | 2019-08-26 | ソルチリン受容体を標的化し血管擬態を阻害するための方法及び化合物 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20220000971A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP3844190A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP7592320B2 (cg-RX-API-DMAC7.html) |
| CN (1) | CN113286820B (cg-RX-API-DMAC7.html) |
| AU (1) | AU2019324747A1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3110414A1 (cg-RX-API-DMAC7.html) |
| IL (1) | IL281043A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2020037434A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3991748A3 (en) | 2015-04-07 | 2022-08-24 | Alector LLC | Anti-sortilin antibodies and methods of use thereof |
| PT3380495T (pt) * | 2015-11-24 | 2021-08-19 | Transfert Plus Sec | Compostos peptídicos e conjugados peptídicos para o tratamento de cancro através de quimioterapia mediada por recetores |
| WO2019032628A1 (en) | 2017-08-07 | 2019-02-14 | The Regents Of The University Of California | GENERATING PLATFORM FOR SAFE CELLULAR THERAPEUTIC AGENTS |
| SMT202300110T1 (it) | 2018-07-13 | 2023-05-12 | Alector Llc | Anticorpi anti-sortilina e relativi metodi di uso |
| CN117320756A (zh) * | 2021-02-26 | 2023-12-29 | 特拉斯福特普拉斯公司 | 用于靶向癌干细胞的方法和结合分拣蛋白的缀合化合物 |
| CA3208147A1 (en) * | 2021-02-26 | 2022-09-01 | Richard Beliveau | Methods and compounds for targeting cancer stem cells |
| CN116731113A (zh) * | 2022-03-01 | 2023-09-12 | 上海智肽生物科技有限公司 | 针对sort1的多肽化合物及其药物偶联物 |
| US20250345446A1 (en) | 2022-06-23 | 2025-11-13 | Draupnir Bio Aps | Bifunctional molecules that selectively induce degradation of extracellular targets in lysosomes |
| WO2024103161A1 (en) * | 2022-11-14 | 2024-05-23 | Theratechnologies Inc. | Drug conjugate compounds for stimulating the antitumor immune response |
| CN122249236A (zh) * | 2023-09-11 | 2026-06-19 | 瑟瑞技术公司 | 喜树碱类似物的肽缀合物及其用途 |
| WO2025208212A1 (en) * | 2024-04-02 | 2025-10-09 | Theratechnologies Inc. | Combination therapies comprising peptide-drug conjugates targeting sortilin |
| WO2025236098A1 (en) * | 2024-05-16 | 2025-11-20 | Theratechnologies Inc. | Peptide conjugates of maytansinoids and uses thereof |
| TW202604936A (zh) * | 2024-07-25 | 2026-02-01 | 大陸商上海湃鴻生物科技有限公司 | 一種多肽藥物偶聯物及其製備方法和應用 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3302488B1 (en) * | 2015-06-03 | 2020-09-30 | Tairx, Inc. | Novel use of aryl-quinolin derivatives as inhibitors of vasculogenic mimicry |
| PT3380495T (pt) * | 2015-11-24 | 2021-08-19 | Transfert Plus Sec | Compostos peptídicos e conjugados peptídicos para o tratamento de cancro através de quimioterapia mediada por recetores |
-
2019
- 2019-08-26 WO PCT/CA2019/051170 patent/WO2020037434A1/en not_active Ceased
- 2019-08-26 US US17/270,787 patent/US20220000971A1/en not_active Abandoned
- 2019-08-26 AU AU2019324747A patent/AU2019324747A1/en not_active Abandoned
- 2019-08-26 CN CN201980069301.0A patent/CN113286820B/zh active Active
- 2019-08-26 EP EP19852741.8A patent/EP3844190A4/en active Pending
- 2019-08-26 JP JP2021534405A patent/JP7592320B2/ja active Active
- 2019-08-26 CA CA3110414A patent/CA3110414A1/en active Pending
-
2021
- 2021-02-23 IL IL281043A patent/IL281043A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2019501141A5 (cg-RX-API-DMAC7.html) | ||
| ES2882634T3 (es) | Compuestos peptídicos y conjugados con péptidos para el tratamiento del cáncer mediante quimioterapia mediada por receptores | |
| JP7592320B2 (ja) | ソルチリン受容体を標的化し血管擬態を阻害するための方法及び化合物 | |
| CN102762586B (zh) | 治疗肽 | |
| CN101501060B (zh) | 用于治疗与异常细胞迁移相关的诸如癌症等疾病的具有药学活性的肽 | |
| CN106132959B (zh) | 用于缀合的细胞毒性微管溶素化合物 | |
| CN112386707B (zh) | 一种肿瘤靶向多肽药物偶联物及其制备方法 | |
| CA3067311A1 (en) | Cd38 antibody drug conjugate | |
| CN103044521B (zh) | 天冬氨酸酶靶向激活的阿霉素衍生物、其制备方法和用途 | |
| CN103732238A (zh) | 用于免疫调节的治疗性化合物 | |
| JP2020508985A5 (cg-RX-API-DMAC7.html) | ||
| ITMI20100093A1 (it) | Peptidi ciclici che legano il recettore cxcr4 e relativi usi in campo medico e diagnostico | |
| KR102224965B1 (ko) | 세포 투과성 펩티드 및 이를 포함하는 컨쥬게이트 | |
| JP2023505298A5 (cg-RX-API-DMAC7.html) | ||
| JP2012505922A5 (cg-RX-API-DMAC7.html) | ||
| CN102036676A (zh) | 新颖的双重靶向性抗肿瘤轭合物 | |
| BG65926B1 (bg) | Кахалалидни съединения | |
| JP2019535702A (ja) | ジンセンチド及びジンセンチド様ペプチドの調製及び使用 | |
| TR201807811T4 (tr) | Bileşikler. | |
| US20200247842A1 (en) | Immune-stimulating soluble doxorubicin-conjugated complex | |
| KR20230167033A (ko) | 암 줄기 세포를 표적화하기 위한 방법 및 소르틸린 결합 접합체 화합물 | |
| CN104910280A (zh) | 一种融合多肽及其在制备抗肿瘤药物中的应用 | |
| US20190015519A1 (en) | Mmp-sensitive taxane prodrug | |
| CN107857800B (zh) | 一种长效整合素抑制剂及其应用 | |
| CN102875651B (zh) | 抗肿瘤靶向激活的多肽阿霉素、其制备方法和用途 |